Cogent Biosciences Inc (COGT)

Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Research and Development	8.18% 52.70	48.72	50.13	38.87	36.04
Costs And Expenses	7.17% 62.40	58.23	59.58	47.09	43.24
Depreciation and Amortization	0.17% 0.599	0.598	0.581	0.562	0.529
Operating Income/Loss	7.17% -62.40	-58.23	-59.58	-47.09	-43.24
Nonoperating Income/Loss	5.00% 4.056	3.863	4.198	3.009	4.65
Income/Loss From Continuing Operations Before Tax	7.33% -58.35	-54.37	-59.58	-44.08	-38.59
Income/Loss From Continuing Operations After Tax	7.33% -58.35	-54.37	-55.38	-44.08	-38.59
Net Income/Loss	7.33% -58.35	-54.37	-55.38	-44.08	-38.59
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,878% 94.80	2.3834	86.17	74.75	70.73
Diluted Average Shares	3,878% 94.80	2.3834	86.17	74.75	70.73
Basic Earnings Per Share	1.59% -0.62	-0.63	-0.64	-0.59	-0.55
Diluted Earnings Per Share	1.59% -0.62	-0.63	-0.64	-0.59	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-